Epibiotech
Pioneering Global Alopecia Therapeutics
Seoul, South Korea · Founded 2015 · $7.2M raised
- Headquarters
- Seoul
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- stemore.co.kr
- Total Funding
- $7.2M
- Last Round
- $7.2M Venture RoundSep 2021
- Rounds
- 1
About
Epibiotech is a South Korean biopharmaceutical company developing cell and antibody treatments for hair restoration and conducting research in skin regeneration for consumer products. The company, formerly Stemore, positions itself as a specialist in alopecia therapeutics and also offers hair-loss preclinical CRO services. Its public English site highlights the Phase 1 program EPI-001 for androgenetic alopecia and recent research on DKK3–CKAP4 signaling. Epibiotech lists GMP-capable facilities and describes itself as an advanced biopharmaceutical developer serving unmet hair-loss medical needs.
Summary
Epibiotech is a Biotech company based in Seoul, South Korea, founded in 2015. It has raised $7.2M in total across 1 round, most recently a $7.2M Venture Round round in Sep 2021.
Funding History
Sep 2021
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/epibiotech"><img src="https://indexed.vc/api/badge/company/epibiotech" alt="Epibiotech on Indexed.vc" width="260" height="76" /></a>